Buy APRE Long Term Easy Gains
Updated
Aprea Therapeutics dropped over 70% in December, and now that it shows strong upside, this stock is pure gold. It is riding around 6.67 right now, and I think that it has the potential to reach up to 30$ this year. I will let you know if you should sell. I have already entered here, but you could wait to buy until it drops into the lower half of the Linear Regression Channel for better value. Like and Follow for more ideas like this! Good Luck
**If you want an example of how these biotechs that drop a lot build back up, take a look at UBX**
**If you want an example of how these biotechs that drop a lot build back up, take a look at UBX**
Note
As you can see, it found the bottom of the channel I made again. This could be a very good entry point. Watch out if it breaks the bottom of the channel though.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.